Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CERE is no longer listed, and 13F filings after Q2 2024 list far fewer holders. See Q2 2024
- Institutional holders
- 2
- −227 vs. Q2 2024
- Shares held
- 472
- −153.4M (−100.0%) vs. Q2 2024
- Total value
- $20.7K
- −$6.27B (−100.0%) vs. Q2 2024
- New holders
- 0
- 1 more added
- Sold out
- 227
- 1 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IFP Advisors, Inc | 346 | $15.5K | 0.00% | −418−54.7% | Reduced |
| Ronald Blue Trust, Inc. | 126 | $5.15K | 0.00% | +7+5.9% | Added |
| Bain Capital Investors LLC | 0 | $0 | 0.00% | −65,679,781−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −10,794,876−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −7,539,547−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −7,154,343−100.0% | Sold out |
| FIL Ltd | 0 | $0 | 0.00% | −3,252,000−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −3,109,886−100.0% | Sold out |
| Alpine Associates Management Inc. | 0 | $0 | 0.00% | −2,353,694−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −2,335,746−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −2,330,508−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −2,151,641−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −2,004,795−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −1,878,719−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −1,869,340−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −1,494,341−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −1,469,670−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −1,347,680−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,284,070−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,233,565−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −1,190,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −1,133,181−100.0% | Sold out |
| Melqart Asset Management (UK) Ltd | 0 | $0 | 0.00% | −1,099,229−100.0% | Sold out |
| HBK Investments L P | 0 | $0 | 0.00% | −1,039,137−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −1,020,921−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −1,014,239−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −955,818−100.0% | Sold out |
| Sand Grove Capital Management LLP | 0 | $0 | 0.00% | −919,023−100.0% | Sold out |
| P Schoenfeld Asset Management LP | 0 | $0 | 0.00% | −796,440−100.0% | Sold out |
| Westchester Capital Management, LLC | 0 | $0 | 0.00% | −793,349−100.0% | Sold out |
| Water Island Capital LLC | 0 | $0 | 0.00% | −766,933−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −697,510−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −683,588−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −645,282−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −609,765−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −596,407−100.0% | Sold out |
| TIG Advisors, LLC | 0 | $0 | 0.00% | −588,255−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −529,071−100.0% | Sold out |
| Tokio Marine Asset Management Co Ltd | 0 | $0 | 0.00% | −530,200−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −522,930−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −508,838−100.0% | Sold out |
| CNH Partners LLC | 0 | $0 | 0.00% | −502,062−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −490,000−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −475,000−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −466,823−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −446,018−100.0% | Sold out |
| Twin Securities, Inc. | 0 | $0 | 0.00% | −416,657−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −393,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −377,431−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −367,973−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −361,400−100.0% | Sold out |
| Gabelli Funds LLC | 0 | $0 | 0.00% | −347,624−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −338,455−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −337,271−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −335,500−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −330,728−100.0% | Sold out |
| Trium Capital LLP | 0 | $0 | 0.00% | −317,731−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −293,385−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −291,457−100.0% | Sold out |
| Stansberry Asset Management, LLC | 0 | $0 | 0.00% | −281,694−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −270,572−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −269,948−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −260,399−100.0% | Sold out |
| Vivaldi Asset Management, LLC | 0 | $0 | 0.00% | −250,985−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −249,362−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −248,027−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −204,808−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −201,743−100.0% | Sold out |
| Governors Lane LP | 0 | $0 | 0.00% | −192,700−100.0% | Sold out |
| Gardner Lewis Asset Management L P | 0 | $0 | 0.00% | −192,150−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −183,293−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −178,765−100.0% | Sold out |
| Great Lakes Advisors, LLC | 0 | $0 | 0.00% | −172,337−100.0% | Sold out |
| Gabelli & Co Investment Advisers, Inc. | 0 | $0 | 0.00% | −164,345−100.0% | Sold out |
| ClearAlpha Technologies LP | 0 | $0 | 0.00% | −149,438−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −143,200−100.0% | Sold out |
| Carmignac Gestion | 0 | $0 | 0.00% | −142,015−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −138,380−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −126,538−100.0% | Sold out |
| Silphium Asset Management Ltd | 0 | $0 | 0.00% | −123,314−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −120,723−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −113,500−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −110,010−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −108,832−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −101,700−100.0% | Sold out |
| Murchinson Ltd. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −97,200−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −93,350−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −90,932−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −87,810−100.0% | Sold out |
| Lake Street Advisors Group, LLC | 0 | $0 | 0.00% | −83,857−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −78,576−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −73,829−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −73,771−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −73,395−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −72,546−100.0% | Sold out |